OPAL DELISSER: Open Payments
NPI 1588857130 · CAMDEN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$65 in 4 payments from 3 companies in 2025. Trend: 2023 $171 · 2024 $308 · 2025 $65
Food & beverage: $65
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 2 | $34 |
| Alnylam Pharmaceuticals Inc. | 1 | $17 |
| Merck Sharp & Dohme LLC | 1 | $14 |
Products named: Repatha, ONPATTRO, VERQUVO.
Industry payments across NJ — which companies pay providers there.
